Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.
- DOI
- 10.3310/yapl9347
- Published
- 2024 Oct
- Container
- Health technology assessment (Winchester, England)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3310/yapl9347,
title = {Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.},
author = {Harnan S and Kearns B and Scope A and Schmitt L and Jankovic D and Hamilton J and Srivastava T and Hill H and Ku CC and Ren S and Rothery C and Bojke L and Sculpher M and Woods B},
year = {2024},
journal = {Health technology assessment (Winchester, England)},
doi = {10.3310/yapl9347},
url = {https://doi.org/10.3310/yapl9347}
}RIS
TY - JOUR TI - Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. AU - Harnan S AU - Kearns B AU - Scope A AU - Schmitt L AU - Jankovic D AU - Hamilton J AU - Srivastava T AU - Hill H AU - Ku CC AU - Ren S AU - Rothery C AU - Bojke L AU - Sculpher M AU - Woods B PY - 2024 JO - Health technology assessment (Winchester, England) DO - 10.3310/yapl9347 UR - https://doi.org/10.3310/yapl9347 ER -
APA
S, H., B, K., A, S., L, S., D, J., J, H., T, S., H, H., CC, K., S, R., C, R., L, B., M, S., & B, W. (2024). Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.. Health technology assessment (Winchester, England). https://doi.org/10.3310/yapl9347
Source records
- pubmed · retrieved 2026-09-26T03:14:12.170Z
- europe-pmc · retrieved 2026-09-26T03:14:12.166Z
- doaj · retrieved 2026-09-26T03:14:12.136Z